research use only
Cat.No.S8964
| Related Targets | HDAC PARP ATM/ATR DNA-PK WRN DNA/RNA Synthesis Topoisomerase PPAR Sirtuin Casein Kinase |
|---|---|
| Other Antineoplastic and Immunosuppressive Antibiotics Inhibitors | Staurosporine (STS) Cyclosporin A Oligomycin A (MCH 32) Puromycin Dihydrochloride Nigericin sodium salt Geldanamycin (NSC 122750) Honokiol Streptozotocin (STZ) Sodium Monensin (NSC 343257) Cephalomannine |
|
In vitro |
DMSO
: 100 mg/mL
(79.65 mM)
Water : Insoluble Ethanol : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about Actinomycin D (Dactinomycin) solubility in DMSO or water
Read more about Actinomycin D (Dactinomycin) working concentrations for cell culture treatment
| Information | Actinomycin D is a potent DNA-intercalating RNA polymerase inhibitor. It affects p53, MAPK, and NF-κB signaling pathways by blocking DNA-dependent RNA synthesis, thereby inhibiting cell proliferation and promoting apoptosis. |
|---|---|
|
Read more about Actinomycin D (Dactinomycin) IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
Read more about Actinomycin D (Dactinomycin) Mechanism of Action
| Molecular Weight | 1255.42 | Formula | C62H86N12O16 |
Storage (From the date of receipt) | 3 years -20°C(in the dark) powder |
|---|---|---|---|---|---|
| CAS No. | 50-76-0 | -- | Storage of Stock Solutions |
|
|
Read more comparative analysis about Actinomycin D (Dactinomycin)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.